In 2024, UAB "GENBA PHARMA" had revenue of 3.5 million EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 3,5m € | 0 € | 0 € -100.0% |
Profit | - -100.0% | 838,9k € +19.0% | 705,3k € |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | - | - | - -100.0% |
Employees | - | - | - |
Overall rating | B68/100 |
Financial health | 50/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Medium |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Female) |
UAB "GENBA PHARMA" is located at Kaunas, Alšėnų g. 2A, LT-46394, LT-LT-46394.
The shareholders of UAB "GENBA PHARMA" include 1 Lithuanian legal entities. View ownership details →
Yes, UAB "GENBA PHARMA" is registered as an active VAT payer with VAT number LT100008885511.
UAB "GENBA PHARMA" was founded on September 18, 2014. The company has been operating for 12 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 12 years | 111 - 115 | 37% | |
Net revenue | 3 505 113,00 € | 44 - 48 | 75% | |
Registered capital | 2896,00 € | - | 10% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Lithuanian register of legal entities.